Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer. - Wikidata - awgldk - TriplyDB

Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.

Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.

http://www.wikidata.org/entity/Q38233046

about

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity IL-15-PI3K-AKT-mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells Understanding of molecular mechanisms in natural killer cell therapy Improving natural killer cell cancer immunotherapy Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.Present and Future of Allogeneic Natural Killer Cell Therapy Aggressive NK-cell leukemia in a 69 years old Caucasian woman: a case report.Electro-Acupuncture Therapy Increases Serum Interferon-γ Levels in Rats with 7, 12 Dimethylbenz(α)anthracene (DMBA)-Induced Breast Tumors Cytokines Induce Faster Membrane Diffusion of MHC Class I and the Ly49A Receptor in a Subpopulation of Natural Killer Cells.Human Cytokine-Induced Memory-Like Natural Killer Cells.Survival in acute myeloid leukemia is associated with NKp44 splice variants.The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.Harnessing NK Cell Memory for Cancer Immunotherapy.In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients.Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcome.CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.First-in-human Phase 1 Clinical Study of the IL-15 Superagonist Complex ALT-803 to Treat Relapse after Transplantation.Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells.Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect.Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.Phosphoinositide-3-Kinase Signaling in Human Natural Killer Cells: New Insights from Primary Immunodeficiency.Impedance-based analysis of Natural Killer cell stimulation.

P2860

Q26773135-35E9CB35-0060-40D5-A62C-08C12869DB9B Q26800159-8A7D7BA8-A628-47DA-B1D6-45A93D815169 Q28086976-38D43644-D6CF-4555-A651-77E58D52A313 Q28087719-A246B83B-195D-4197-BF19-779EA065CCD2 Q33703046-10DAED82-621C-49F5-AD86-2B70FABBDCED Q35677351-8CB150BF-0567-497D-BD93-B60FF7F86F7B Q36355702-28441B5F-4486-4AC2-B341-9262B4D2A8EB Q36404530-DB21F1F0-1E8C-44C6-B36D-BF970899588F Q36541125-80DF3FF1-591C-4889-ADDE-91C8EB54E36E Q36830628-88F128E9-6FC3-4885-8FB2-910FBAC74CA5 Q37362807-63423A16-5BDE-49CD-ABA4-E6A759F17BF8 Q38831202-BD5E73E6-41E9-4900-92AE-9EA9A3F572B6 Q38928938-C4E37D39-F0BC-4B7A-8EE3-9C2BFD9F9337 Q38988913-FBA55D0A-F8B4-49F0-A4F4-7C326DA3CD7A Q41269711-F1101FFB-EB0A-458E-BC53-FAB4FCFA175D Q41321384-7C8A6DA9-7108-43F4-ABC7-6893A5E1F6C3 Q41351026-4530216A-D953-4BFC-A949-E5175F3F42C1 Q41991684-4375D01A-65D1-46D3-839A-E58516A08DEE Q42380131-8C06C9FE-AC6D-4D04-AE7C-E19BFC9711FB Q42660142-4374F5D8-B030-488B-85B2-A6012CDED646 Q49791810-8F19AEAA-53AB-437A-9DB3-4F747B012E6C Q50042227-72CD3A54-E7CE-4920-8D27-44D48106D4E6 Q50130502-AB9BEC10-B505-40C0-AF0B-A14D4CE1B4AB Q50204340-893617E7-7440-4E5F-A7DF-1553BD8D0C55 Q52643680-098E4176-7488-4CCA-8218-E8BEA426011E Q55284365-086E43A7-3BC0-43E8-9311-192938DDF61E

P2860

Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.

http://www.wikidata.org/entity/Q38233046

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.

@en

type

label

Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.

@en

prefLabel

Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.

@en

P1433

Q38233046-98926C01-A817-4B58-AA7A-6DBB482481EA

P1476

Q38233046-0A3DA61B-66EF-47B0-B0EB-46E76D642AC9

P2093

Q38233046-26B62BF5-FF37-4583-A150-A97FEB6D76B8

Q38233046-B80B1A9E-9CDE-4347-AC2C-1E26F23EA869

Q38233046-DCD7DE27-086E-4F96-BCD5-9E8B5143BE25

P2860

Q38233046-01A1AED2-3218-4611-86C2-5A27A04FE70C

Q38233046-01D3C05F-2701-441C-9C09-74BC7CC0F8E1

Q38233046-0217410C-76A3-4F1D-B700-740D7C562981

Q38233046-041B2BA9-4D41-4DB8-9595-73829420B02B

Q38233046-05A08BDA-1CA4-41E1-A147-9C622C1AAF83

Q38233046-0677DECF-DDD2-48CA-95C6-54833DAD6199

Q38233046-0808370E-F6F2-4C9C-B5B3-196137E3FEE6

Q38233046-0B0EE8A7-C946-4C40-BCB6-BC865566E875

Q38233046-0B568108-DDD1-412F-A287-83C5A8BAEF7A

Q38233046-0E849961-86A5-41F2-8A1A-F517502D4C38

P304

Q38233046-FADE8D04-EA01-4321-94A3-EFFFAAE0D5BA

P31

Q38233046-A59B9370-6038-4731-ACCC-D5C42A70E473

P356

Q38233046-DA00AE37-A653-41C6-9137-FF1CC3BAECAA

P478

Q38233046-6CD924DE-723B-4C64-AEDB-A56B92EE4DA2

P577

Q38233046-123B8176-A413-445A-B1BF-9D98A182AB91

P5875

Q38233046-EB19A8CD-0809-4CF4-AA5A-9CDFD6205A18

P698

Q38233046-8F4E8097-30F4-4231-BC1F-C4AB37A35A6F

P921

Q38233046-E5AC4C15-9356-4598-BE98-8E5FA3ED1D34

P932

Q38233046-D7F83DFA-6A25-4140-8DC7-9E0BF6E8921B

P356

P1433

P1476

Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.

@en

P2093

Jeffrey W Leong

http://www.w3.org/2001/XMLSchema#string

Rizwan Romee

http://www.w3.org/2001/XMLSchema#string

Todd A Fehniger

http://www.w3.org/2001/XMLSchema#string

P2860

IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21

Interleukin-2 receptor signaling: at the interface between tolerance and immunity

Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain

Natural killer cells and autoimmunity

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells

IL-21 induces the functional maturation of murine NK cells

Functions of natural killer cells

NK cell recognition

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

P304

205796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/205796

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263452743

http://www.w3.org/2001/XMLSchema#string

P698

25054077

http://www.w3.org/2001/XMLSchema#string

P921

P932

4099226

http://www.w3.org/2001/XMLSchema#string